Biosite Inc. Recalls Cardiac Marker Test

Law360, New York (May 6, 2009, 12:00 AM EDT) -- Research-based diagnostics company Biosite Inc. has issued a nationwide recall of one lot of its Triage Cardiac Panel, a product used to diagnose heart attacks, because of a defect that could possibly lead to a wrong diagnosis.

On Tuesday, the company voluntarily recalled 401 of its Triage Cardiac Panel kits because of “reports of low recovery of quality control samples containing Creatine Kinase MB (CK-MB), troponin I and myoglobin on the affected lot."

“Although there have been no reported issues of patient misdiagnosis associated with this...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.